Cüneyt Türkeş

27PUBLICATIONS
42CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Mar 25, 2026
The Effects of Apilarnil and Imatinib on GR/GST/TrxR1 Enzyme Activities and Pentose Phosphate Pathway Enzymes in Rats.

Adnan Ayna, Cuneyt Caglayan, Cüneyt Türkeş

|Feb 27, 2026
Design and Synthesis of 4-Arylazo Pyrazole Carboxamides as Dual AChE/BChE Inhibitors: Kinetic and In Silico Evaluation.

Suleyman Akocak, Nebih Lolak, Hatice Esra Duran

|Jan 28, 2026
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity.

Belgin Sever, Cüneyt Türkeş, Yeliz Demir

|Jan 18, 2026
Isovanillin-derived bis-hydrazones as dual cholinesterase and carbonic anhydrase inhibitors: synthesis, enzymatic profiling, and computational insights from molecular docking and dynamics.

Cüneyt Türkeş, Gönül Yapar, Hatice Esra Duran

|Nov 04, 2024
Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity.

Aida Buza, Cüneyt Türkeş, Mustafa Arslan

|Oct 28, 2024
Synthesis, α-Glucosidase, α-Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2-<i>a</i>]pyridine Derivatives.

Betül Kaya, Ulviye Acar Çevik, Bilge Çiftçi

Pageof 5

Frequent Collaborators

14 joint publications

Şükrü Beydemir

7 joint publications

Yeliz Demir

5 joint publications

Mustafa Arslan

3 joint publications

Parham Taslimi